Yeo, Alan T.
Rawal, Shruti
Delcuze, Bethany
Christofides, Anthos
Atayde, Agata
Strauss, Laura
Balaj, Leonora
Rogers, Vaughn A. http://orcid.org/0000-0002-6423-5197
Uhlmann, Erik J.
Varma, Hemant
Carter, Bob S.
Boussiotis, Vassiliki A. http://orcid.org/0000-0002-3963-1518
Charest, Al http://orcid.org/0000-0002-1548-6950
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA229784)
Article History
Received: 21 May 2021
Accepted: 18 April 2022
First Online: 27 May 2022
Competing interests
: V.A.B. has patents on the PD-1 pathway licensed by Bristol-Myers Squibb, Roche, Merck, EMD-Serono, Boehringer Ingelheim, AstraZeneca, Novartis and Dako. The other authors declare no competing interests.